Background. Increasing evidence suggests that the cervicovaginal microbiota (CVM) plays an important role in acquiring sexually transmitted infections (STIs). Here we study the CVM in a population of women notified by a sex partner for Chlamydia trachomatis infection.
Netherlands, who test positive for an STI are encouraged to notify their sex partners and are provided with an official contact-tracing slip to give to their sex partners. Here we collected cervicovaginal samples and demographic and clinical data from women presenting with such a C. trachomatis contact-tracing slip and compared the CVM of women testing positive for C. trachomatis to the CVM of women testing negative for C. trachomatis.
METHODS

Study Population and Sample Collection
Our study was conducted at the STI clinic in Amsterdam, the Netherlands. Clients of the STI clinic are notified that remainders of their samples may be used for scientific research after anonymization. If clients object, their samples and data are discarded. This procedure was approved by the Amsterdam University Medical ethical committee (reference number W15_159, number 15.0193). For this study, we retrieved processed samples and data from women who had presented with a C. trachomatis contact-tracing slip at the STI clinic. During the timeframe of sample collection for this study, no contact-traced women objected to their data being used. As part of routine management, nurse-collected cervical and/or vaginal swabs were used for C. trachomatis testing, using the single Chlamydia trachomatis TMA assay up to May 2014, and the combo Chlamydia trachomatis/Neisseria gonorrhoeae TMA assay (APTIMA, Hologic, Bedford, Massachusetts) assays thereafter. All samples retrieved for this study were stored at −80°C until further processing. Vaginal smears, when available, were Gram stained and assessed by the Nugent score [15] . A data manager collected and anonymized demographic and clinical data from electronic patient files.
DNA Extraction
Samples were thawed on ice and vortexed vigorously. A 500-µL aliquot was transferred to a sterile 2-mL Lysating Matrix Tube B (MPBio, Leicester, United Kingdom,). Samples were lysed with lysozyme (10 mg/mL; Sigma-Aldrich, St Louis, Missouri), mutanolysin (>4 U/µL; Sigma-Aldrich), lysostaphin (1 mg/mL; AMBI, Lawrence, New York), proteinase K (20 mg/mL; Thermo Fisher, Waltham, Massachusetts), and Rnase A (10 mg/mL; Thermo Fisher). A mechanical bead beating step followed, at 5 m/s for 40 seconds (MagnaPure, Roche Diagnostics, Basel, Switzerland). DNA was extracted from the crude lysates using the ChemaGen extraction robot (PerkinElmer, Baesweiler, Germany,). DNA templates were measured using the Quant-iT PicoGreen dsDNA assay (Thermo Fisher) and normalized to contain a maximum DNA concentration of 5 ng/µL. DNA templates were stored at −80°C until further processing.
16S rRNA Gene Amplification and Illumina MiSeq Sequencing
Dual indexed universal primers 319F and 806R were used for polymerase chain reaction (PCR) amplification of the V3-V4 hypervariable regions of the 16S rRNA genes, as previously described by Fadrosh et al [16] . PCR reactions were performed using a Gene Amp PCR System 9700 (Applied Biosystem, Carlsbad, California) using Phusion Mix (Thermo Fisher) and 5-25 ng of extracted DNA in a total volume of 25 µL. PCR products were quantified using the Quant-iT PicoGreen dsDNA assay (Thermo Fisher) and pooled, with each sample contributing a maximum of 125 ng amplified DNA to the pool. The pooled sample was purified with Agencourt AMPure XP magnetic beads (Beckman Coulter, Brea, California).
Raw Data Cleaning
Unaligned sequences underwent quality control; only keeping sequences with >99.9% base call accuracy (Trimmomatic tool; [17] ) and sequences were aligned and truncated (keeping sequences of >400 bp) using PandaSeq [18] . Primers were trimmed off the aligned sequences using a sliding door approach with tagcleaner [19] . Aligned sequences were mapped to their corresponding barcodes using the de-multiplex tool in QIIME, version 1.9 [20] . Operational taxonomic units (OTUs) were picked using the usearch tool in QIIME at 97% identity. A representative sequence for each OTU was taken forward and aligned to a template of sequences from the vaginal 16S reference package developed by Srinivasan et al [11] , using the PyNAST alignment tool in QIIME with uclust clustering [21] .
Taxonomic Classification
Taxonomic classification of the representative OTUs was done by heuristic phylogenetic placement of query sequences, using PPLACER [22] . We used the previously published vaginal 16S reference package for our analysis [11] . Common OTUs in our dataset that could not be identified to a species level using the vaginal reference package were searched using BLAST and assigned to the deepest taxonomical level based on available published data. Relative abundances per taxonomy were calculated per sample. Samples with <100 reads were excluded from CVM analysis. Cluster analysis was performed in R (version 3.2.1) [23] . A dendrogram based on the maximum distance in matrix dissimilarity between relative abundances per sample was created using the ggplot2 package in R [24] .
Statistical Analysis
All statistical analyses were performed in SPSS Statistics software version 21 (IBM). Differences in study population characteristics were tested using the χ 2 , Fisher exact (when the expected value was <5), or Mann-Whitney U test, accordingly. To examine whether the CVM was associated with C. trachomatis infection, we performed a bivariable and multivariable logistic regression analysis. We used a directed acyclic graph to identify other variables that could be associated with C. trachomatis infection [25] . In univariable analysis, we assessed the effect of the CVM, age (≤21 or >21 years), ethnicity, Nugent score, clinical diagnosis of bacterial vaginosis, and determinants of sexual behavior (number of sex partners in the preceding 6 months, condom use at last sex act, and type of last sex partner [steady or nonsteady]). Variables that did not display collinearity and that were associated with C. trachomatis infection at P ≤ .1 in univariable analysis were entered into a multivariable model. In the multivariable model we considered P < .05 as statistically significant. Additionally, to evaluate which bacterial taxa were most likely to explain the difference in CVM with respect to C. trachomatis infection, we performed a linear discriminant analysis effect size analysis with α set to .05 [26] .
RESULTS
Study Population
From September 2013 to December 2014, we included samples and data from 98 women who had presented themselves at the STI clinic with a contact-tracing slip indicating that a sex partner had tested positive for C. trachomatis. Five women testing positive for C. trachomatis were excluded from statistical analyses as their CVM could not be determined. Of the 93 remaining women, 41 tested C. trachomatis negative and 52 tested C. trachomatis positive. Nugent scores were performed for 47 women; 29 of these women were C. trachomatis negative and 18 women were C. trachomatis positive. The C. trachomatispositive and C. trachomatis-negative groups were similar in most demographic and behavioral characteristics (Table 1) . Differences in the following 2 characteristics were of note: (1) (2) the C. trachomatis-positive women were more likely to report that their last sex act was with a steady partner, as opposed to a nonsteady partner (P = .005).
Cervicovaginal Microbiota Clusters
The 93 included women provided 46 vaginal and 82 cervical samples ( Figure 1 ). An average of 25 357 reads were generated per sample, with cervical samples producing fewer reads than vaginal samples (median, 13 700 [IQR, 1699-33 290] and 34 375 [IQR, 20 258-50 185], respectively). In total, 230 OTUs were generated and allocated to 101 different taxonomies with a minimum likelihood >0.8. We identified 3 major CVM clusters ( Figure 2 ). These CVMs either predominantly consisted of di-
. Two women had discordant cervical/vaginal cluster allocations; in that case the cervical cluster was used for statistical analysis (Figure 1 ). Values in boldface are statistically significant at P < .05. ( Table 2 ). In univariable analysis, ethnicity was not associated with C. trachomatis infection (P = .502), nor was condom use (P = .606), or clinical diagnosis of BV (P = .422). steady sex partner (OR, 3.6 [95% CI, 1.4-9.4]; P = .009, compared with a nonsteady partner). In the linear discriminant analysis effect size analysis (Figure 3) , L. iners, L. crispatus, Lactobacillus vaginalis, Lachnospiraceae, Gemella, BVAB3, and Actinomyces urogenitalis were the species that showed statistically and biologically consistent differences between women who had C. trachomatis infection and women who were not infected. However, apart from L. crispatus and L. iners, these species were rare (<1% abundance) within this population. The results indicate that L. iners was associated with having C. trachomatis infection, whereas L. crispatus was not associated with C. trachomatis infection.
DISCUSSION
All women included in this study were assumed to be exposed recently to C. trachomatis by a sexual partner with proven C. trachomatis infection. We compared the CVM of women with a chlamydial infection to those without. We found that women testing positive for C. trachomatis infection were more likely to have a CVM dominated by L. iners or diverse anaerobic bacteria than by L. crispatus. Furthermore, C. trachomatis positivity was more likely to occur in young women (≤21 vs >21 years old) and women reporting a steady sexual partner, as opposed to a casual partner.
Presumably, most individuals in our study were exposed to C. trachomatis in just a few days or weeks prior to sampling, as more than half of contact-traced individuals came to the STI clinic within 3 days and >95% within 3 weeks according to a study performed in 2010 at the STI clinic in Amsterdam (unpublished data). Studies looking into spontaneous clearance of C. trachomatis are scarce, but the available data suggest that clearance can take from several weeks to several years [27, 28] . Therefore, it is unlikely that a spontaneous clearance of C. trachomatis infection could have occurred in the C. trachomatis-negative group. Values in boldface are statistically significant at P < .05.
Abbreviations: BV, bacterial vaginosis; CI, confidence interval; OR, odds ratio. a Non-European ethnicity was as follows: n = 9 (30%) African; n = 12 (43.3%) Dutch Antilles; n = 5 (16.7%) Asian; n = 2 (6.7%) Central or South American; and n = 1 (3.3%) other ethnicity.
b Data missing on condom use (n = 3), steady sex partner (n = 4), and Nugent score (n = 46).
c Clinical BV was diagnosed in the presence of vaginal discharge, clue cells, and a positive whiff test. Figure 3 . Bacterial taxa that showed statistically and biologically consistent differences between women with and without Chlamydia trachomatis infection. Bacterial taxa were compared using a linear discriminant analysis (LDA) effect size analysis with α set to .05. Bar plots in black show LDA scores of taxa more prevalent in C. trachomatispositive samples, and bar plots in white show LDA scores of taxa more prevalent in C. trachomatis-negative samples.
Only 1 other study examined the CVM in relation to C. trachomatis infection in C. trachomatis contact-traced women [5] . As in our study, they found that women with C. trachomatis infection were >3 times more likely to have vaginal dysbiosis, compared with having lactobacilli-dominated CVM [5] . Furthermore, a large prospective cohort study of vaginal microbiota in relation to STI (n = 3620 women followed quarterly for 1 year), using the Nugent score, found that intermediate and BV-like Nugent scores were associated with a 1.5-to 2-fold increased risk for incident Trichomonas vaginalis, N. gonorrhoeae, or C. trachomatis infection [3] . Similarly, Gallo et al found that the odds for C. trachomatis infection increased by 1.6-fold in women who had BV based on Amsel criteria [29] . Other longitudinal studies have found comparable, albeit statistically nonsignificant, point estimates for increased chlamydial infection incidence among women with BV [14, 30] . We also performed a longitudinal study in which the composition of the CVM of women 1 year before they were diagnosed with C. trachomatis was assessed using 16S rRNA sequencing [12] . These data showed, similar to our current findings, that L. crispatus dominance was not associated with C. trachomatis infection, whereas L. iners was associated. Findings based on BV diagnoses by Nugent scores or Amsel criteria alone, may therefore give conservative estimates for association between the CVM and C. trachomatis infection as women with CVM dominated by L. iners, by definition, have healthy Nugent scores and do not fulfill the Amsel criteria for BV. Observational studies, using molecular tools, have also found that L. iners dominance was associated with STI prevalence [11, 31] .
The link between lactobacilli and vaginal health is often attributed to the production of lactic acid. This acidifies the vagina ( pH < 4.5) and restricts growth of other ( pathogenic) organisms. Besides acidification, Witkin and colleagues propose that an L. crispatus-induced low L/D-lactic acid ratio may also help protect against STIs by reducing host gene expression of matrix metalloproteinase and so keeping the endocervical barrier intact [32] . Also, others have found that L. crispatus inhibits adhesion and infectivity of C. trachomatis in human epithelial cells and that it reduces severe inflammation by stimulating the production of the anti-inflammatory cytokine interleukin (IL) 10 and reduces the production of the proinflammatory cytokines IL-6, IL-8, and tumor necrosis factor α [33, 34] . Lactobacillus iners, on the other hand, does not seem to be able to produce D-lactic acid, as in vitro and genome analyses have indicated [32] . Rather, L. iners likely metabolizes its carbohydrate source (mostly glycogen) into succinate and short-chain fatty acids, resulting in a pH > 4.5 [32, 35, 36] . Given the relatively small genome of L. iners (1.32 Mb, compared with 1.62-2.17 Mb for other common vaginal Lactobacillus species), it is plausible that symbiotic relationships with other vaginal bacteria exist that allow L. iners to survive under differing vaginal conditions, possibly even differentially expressing approximately 10% of its genome during healthy or dysbiotic states [32, 36] . If so, L. iners could possibly reflect a transitional phase from healthy to BV-like state, or vice-versa.
A strength of our study is that we have included a substantial number of well-characterized C. trachomatis cases and controls who had all been warned for chlamydial infection. However, the cross-sectional nature of our data limits any inference of causality-that is, we do not know the CVM composition prior to exposure to C. trachomatis and to what extent the C. trachomatis infection is driving the CVM composition. Drivers of the CVM composition in reproductive-age women have not yet been fully described, but it has been suggested that factors such as hormonal contraception, recent sexual intercourse, vaginal douching, menses, and also STIs could impact the CVM composition and possibly cause fluctuations in CVM composition over time [29, 35, [37] [38] [39] . As we do not have information on all of the aforementioned variables, it is possible that residual confounding exists in our data. Regarding sexual risk behavior, we found that C. trachomatis-positive women were more likely to report a steady sexual partner, as opposed to a casual partner. This association with C. trachomatis infection can possibly be explained by more frequent sex with a steady partner (transmission per partnership) than with a casual partner (transmission per sex act).
Our study is also limited by its single-center design in that the majority of the included women (approximately 70%) were of Dutch ethnic origin and we have recently shown that women of Dutch ethnic origin are less likely to have vaginal dysbiosis compared with women of other ethnicities residing in Amsterdam, the Netherlands [40] . As the prevalence of different CVM compositions may differ between ethnic groups (also described by Ravel et al [6] ), the association between the CVM and C. trachomatis infection should be assessed in different ethnic cohorts. Furthermore, prospective cohort studies, using molecular tools, are needed so that the moment of STI exposure can be estimated and CVMs prior to and after infection can be compared.
To conclude, in a population of women who were notified for chlamydial infection, we found that those who tested positive for C. trachomatis infection were more likely to be younger, have a steady partnership, and were more likely to have CVMs dominated by L. iners or diverse anaerobic bacteria than by L. crispatus. Our findings warrant further epidemiological and fundamental research to guide intervention strategies for women at risk for contracting chlamydia.
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